好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Bridging with Neurointerventional Therapy Following Full Dose Intravenous Alteplase Is Safe in Octogenerians with Acute Ischemic Stroke
Cerebrovascular Disease and Interventional Neurology
(-)
159
Authors/Disclosures
Ugo Paolucci, MD (CUMC) No disclosure on file
Amtul Farheen, MD, FAAN (Jackson VA Medical Center) Dr. Farheen has nothing to disclose.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
No disclosure on file
No disclosure on file
Martin Gizzi, MD, PhD, FAAN No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Jorge D. Correale, MD (Institute for Neurological Research) Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .